Rush Island Management LP Purchases Shares of 1,598,287 Sabra Healthcare REIT, Inc. $SBRA

Rush Island Management LP acquired a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the first quarter, Holdings Channel.com reports. The fund acquired 1,598,287 shares of the real estate investment trust’s stock, valued at approximately $30,735,000. Sabra Healthcare REIT comprises about 2.1% of Rush Island Management LP’s holdings, making the stock its 15th biggest holding.

Other large investors have also modified their holdings of the company. Focus Partners Wealth raised its position in shares of Sabra Healthcare REIT by 11.4% during the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the period. First Trust Advisors LP increased its stake in Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after purchasing an additional 78,709 shares in the last quarter. Cerity Partners LLC increased its stake in Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock worth $345,000 after purchasing an additional 7,885 shares in the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in Sabra Healthcare REIT by 3.1% during the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after buying an additional 2,557 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Stock Down 0.6%

NASDAQ:SBRA opened at $22.26 on Wednesday. The business’s fifty day moving average price is $19.73 and its 200 day moving average price is $19.88. The firm has a market capitalization of $5.61 billion, a price-to-earnings ratio of 35.33, a PEG ratio of 1.73 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. During the same period last year, the company posted $0.37 EPS. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on SBRA. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Truist Financial boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Robert W. Baird upped their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a research report on Wednesday, July 22nd. Finally, Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.25.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.